Finding the right combination antiviral therapy for influenza

被引：10

作者：

Ison, Michael G. ^{[1
,2
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA

[2] Northwestern Univ, Feinberg Sch Med, Div Organ Transplantat, Chicago, IL 60611 USA

来源：

LANCET INFECTIOUS DISEASES | 2017年 / 17卷 / 12期

关键词：

OSELTAMIVIR; VIRUSES; AMANTADINE; RESISTANCE; RIBAVIRIN; SAFETY;

D O I：

10.1016/S1473-3099(17)30537-6

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：1221 / 1222

页数：3

共 15 条

[1]

Beigel JH, 2017, LANCET INFECT DIS

[2] Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study [J].

Beigel, John H. ;

Tebas, Pablo ;

Elie-Turenne, Marie-Carmelle ;

Bajwa, Ednan ;

Bell, Todd E. ;

Cairns, Charles B. ;

Shoham, Shmuel ;

Deville, Jaime G. ;

Feucht, Eric ;

Feinberg, Judith ;

Luke, Thomas ;

Raviprakash, Kanakatte ;

Danko, Janine ;

O'Neil, Dorothy ;

Metcalf, Julia A. ;

King, Karen ;

Burgess, Timothy H. ;

Aga, Evgenia ;

Lane, H. Clifford ;

Hughes, Michael D. ;

Davey, Richard T. .

LANCET RESPIRATORY MEDICINE, 2017, 5 (06) :500-511

[3] Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern [J].

Bright, RA ;

Medina, MJ ;

Xu, XY ;

Perez-Oronoz, G ;

Wallis, TR ;

Davis, XHM ;

Povinelli, L ;

Cox, NJ ;

Klimov, AI .

LANCET, 2005, 366 (9492) :1175-1181

[4] Antiviral combinations for severe influenza [J].

Dunning, Jake ;

Baillie, J. Kenneth ;

Cao, Bin ;

Hayden, Frederick G. .

LANCET INFECTIOUS DISEASES, 2014, 14 (12) :1259-1270

[5] Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial [J].

Duval, Xavier ;

van der Werf, Sylvie ;

Blanchon, Thierry ;

Mosnier, Anne ;

Bouscambert-Duchamp, Maude ;

Tibi, Annick ;

Enouf, Vincent ;

Charlois-Ou, Cecile ;

Vincent, Corine ;

Andreoletti, Laurent ;

Tubach, Florence ;

Lina, Bruno ;

Mentre, France ;

Leport, Catherine .

PLOS MEDICINE, 2010, 7 (11)

[6] Newer influenza antivirals, biotherapeutics and combinations [J].

Hayden, Frederick G. .

INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 :63-75

[7]

Ison MG, 2003, ANTIVIR THER, V8, P183

[8] Characterization of Drug-Resistant Influenza A(H7N9) Variants Isolated From an Oseltamivir-Treated Patient in Taiwan [J].

Marjuki, Henju ;

Mishin, Vasiliy P. ;

Chesnokov, Anton P. ;

Jones, Joyce ;

De La Cruz, Juan A. ;

Sleeman, Katrina ;

Tamura, Daisuke ;

Nguyen, Ha T. ;

Wu, Ho-Sheng ;

Chang, Feng-Yee ;

Liu, Ming-Tsan ;

Fry, Alicia M. ;

Cox, Nancy J. ;

Villanueva, Julie M. ;

Davis, Charles T. ;

Gubareva, Larisa V. .

JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (02) :249-257

[9] Antiviral therapies on the horizon for influenza [J].

Naesens, Lieve ;

Stevaert, Annelies ;

Vanderlinden, Evelien .

CURRENT OPINION IN PHARMACOLOGY, 2016, 30 :106-115

[10] Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods [J].

Nguyen, Ha T. ;

Fry, Alicia M. ;

Gubareva, Larisa V. .

ANTIVIRAL THERAPY, 2012, 17 (01) :159-173

← 1 2 →